• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BKL
Click for more information
3.89% $80.96

BLACKMORES LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
BKLAmended Half Year Results and Shareholder Letter26/02/14
BKLHalf Year Letter to Shareholders26/02/14
BKLHalf Year Results Announcement26/02/14
BKLHalf Yearly Report and AccountsPRICE SENSITIVE26/02/14
BKLCompany Secretary Appointment/Resignation12/02/14
BKLAppendix 3B04/02/14
BKLShare Price MovementPRICE SENSITIVE08/11/13
BKLChange of Director's Interest Notice22/10/13
BKLChange of Director's Interest Notice22/10/13
BKLChange of Director's Interest Notice22/10/13
BKLFinal Director's Interest Notice22/10/13
BKLInitial Director's Interest Notice22/10/13
BKLInitial Director's Interest Notice22/10/13
BKLResults of Meeting22/10/13
BKLChairman's Address to Shareholders22/10/13
BKLQ1 Letter to Shareholders / Director Changes22/10/13
BKL1Q Results / Director ChangesPRICE SENSITIVE22/10/13
BKLAppendix 3B18/10/13
BKLDividend Reinvestment Plan11/10/13
BKLNotice of Annual General Meeting/Proxy Form17/09/13
BKLAmended Blackmores Full Year Results28/08/13
BKLAnalysts Briefing28/08/13
BKLFourth Quarter Letter to Shareholders28/08/13
BKLBlackmores Full Year Results28/08/13
BKLAnnual Report to shareholders27/08/13
BKLPreliminary Final ReportPRICE SENSITIVE27/08/13
BKLAppendix 3B04/07/13
BKLAnalyst Briefing15/05/13
BKLThird Quarter Letter to Shareholders23/04/13
BKLThird Quarter Results AnnouncementPRICE SENSITIVE23/04/13
BKLChange of Director's Interest Notice10/04/13
BKLChange of Director's Interest Notice10/04/13
BKLChange of Director's Interest Notice10/04/13
BKLChange of Director's Interest Notice10/04/13
BKLChange of Director's Interest Notice10/04/13
BKLAppendix 3B09/04/13
BKLDividend Reinvestment Plan25/03/13
BKLAmended Appendix 4D28/02/13
BKLAnalysts Briefing28/02/13
BKLHalf Year Letter to Shareholders28/02/13
BKLHalf Year Results Announcement28/02/13
BKLHalf Yearly Report and AccountsPRICE SENSITIVE28/02/13
BKLAppendix 3B03/01/13
BKLChange of Director's Interest Notice14/12/12
BKLCompany Secretary Appointment/Resignation04/12/12
BKLFinal Director's Interest Notice31/10/12
BKLResults of Meeting25/10/12
BKLChairman's Address to Shareholders25/10/12
BKLFirst Quarter Letter to Shareholders25/10/12
BKLFirst Quarter Results AnnouncementPRICE SENSITIVE25/10/12
BKLChange of Director's Interest Notice22/10/12
BKLChange of Director's Interest Notice22/10/12
BKLChange of Director's Interest Notice22/10/12
BKLChange of Director's Interest Notice22/10/12
BKLChange of Director's Interest Notice22/10/12
BKLAppendix 3B18/10/12
BKL2012 Final Dividend DRP Share Price11/10/12
BKLNotice of Annual General Meeting/Proxy Form21/09/12
BKLChange of Director's Interest Notice14/09/12
BKLAppendix 4E - Amended30/08/12
BKLAnalysts Briefing30/08/12
BKLFourth Quarter Letter to Shareholders29/08/12
BKLBlackmores Full Year Results29/08/12
BKLAnnual Report to Shareholders29/08/12
BKLAppendix 4EPRICE SENSITIVE29/08/12
BKLAppendix 3B12/07/12
BKLCompletion of Acquisition of FIT-BioCeuticals Limited05/07/12
BKLAnalyst Briefing03/07/12
BKLAcquisition of FIT-BioCeuticals LimitedPRICE SENSITIVE02/07/12
BKLThird Quarter Letter to Shareholders19/04/12
BKLThird Quarter Results AnnouncementPRICE SENSITIVE19/04/12
BKLChange in substantial holding28/03/12
BKLChange of Director's Interest Notice20/03/12
BKLChange of Director's Interest Notice20/03/12
BKLAnalyst Briefing24/02/12
BKLHalf Yearly Report and AccountsPRICE SENSITIVE23/02/12
BKLHalf Year Results Announcement23/02/12
BKLHalf Year Letter to Shareholders23/02/12
BKLAppendix 3B11/01/12
BKLResults of Meeting27/10/11
BKLChairman's Address to Shareholders27/10/11
BKLFirst Quarter Results AnnouncementPRICE SENSITIVE27/10/11
BKLFirst Quarter Letter to Shareholders27/10/11
BKLNotice of Annual General Meeting/Proxy Form23/09/11
BKLChange of Director's Interest Notice01/09/11
BKLAppendix 3B01/09/11
BKLAnalyst Briefing18/08/11
BKLFourth Quarter Letter to Shareholders18/08/11
BKLBlackmores Full Year Results18/08/11
BKLAnnual Report to shareholders18/08/11
BKLAppendix 4EPRICE SENSITIVE18/08/11
BKLAppendix 3B08/07/11
BKLCEO Presentation, Stockbrokers Association of Australia30/05/11
BKLAnalysts Briefing18/05/11
BKLAnalyst Briefing21/04/11
BKLThird Quarter Letter to Shareholders20/04/11
BKLThird Quarter Results AnnouncementPRICE SENSITIVE20/04/11
BKLTrading Policy - Blackmores Shares - Revised24/02/11
BKLAnalyst Briefing23/02/11
BKLHalf Year Letter to Shareholders22/02/11
BKLAmended Half Year Results and Shareholder Letter
26/02/14
BKLHalf Year Letter to Shareholders
26/02/14
BKLHalf Year Results Announcement
26/02/14
BKLHalf Yearly Report and Accounts
26/02/14PRICE SENSITIVE
BKLCompany Secretary Appointment/Resignation
12/02/14
BKLAppendix 3B
04/02/14
BKLShare Price Movement
08/11/13PRICE SENSITIVE
BKLChange of Director's Interest Notice
22/10/13
BKLChange of Director's Interest Notice
22/10/13
BKLChange of Director's Interest Notice
22/10/13
BKLFinal Director's Interest Notice
22/10/13
BKLInitial Director's Interest Notice
22/10/13
BKLInitial Director's Interest Notice
22/10/13
BKLResults of Meeting
22/10/13
BKLChairman's Address to Shareholders
22/10/13
BKLQ1 Letter to Shareholders / Director Changes
22/10/13
BKL1Q Results / Director Changes
22/10/13PRICE SENSITIVE
BKLAppendix 3B
18/10/13
BKLDividend Reinvestment Plan
11/10/13
BKLNotice of Annual General Meeting/Proxy Form
17/09/13
BKLAmended Blackmores Full Year Results
28/08/13
BKLAnalysts Briefing
28/08/13
BKLFourth Quarter Letter to Shareholders
28/08/13
BKLBlackmores Full Year Results
28/08/13
BKLAnnual Report to shareholders
27/08/13
BKLPreliminary Final Report
27/08/13PRICE SENSITIVE
BKLAppendix 3B
04/07/13
BKLAnalyst Briefing
15/05/13
BKLThird Quarter Letter to Shareholders
23/04/13
BKLThird Quarter Results Announcement
23/04/13PRICE SENSITIVE
BKLChange of Director's Interest Notice
10/04/13
BKLChange of Director's Interest Notice
10/04/13
BKLChange of Director's Interest Notice
10/04/13
BKLChange of Director's Interest Notice
10/04/13
BKLChange of Director's Interest Notice
10/04/13
BKLAppendix 3B
09/04/13
BKLDividend Reinvestment Plan
25/03/13
BKLAmended Appendix 4D
28/02/13
BKLAnalysts Briefing
28/02/13
BKLHalf Year Letter to Shareholders
28/02/13
BKLHalf Year Results Announcement
28/02/13
BKLHalf Yearly Report and Accounts
28/02/13PRICE SENSITIVE
BKLAppendix 3B
03/01/13
BKLChange of Director's Interest Notice
14/12/12
BKLCompany Secretary Appointment/Resignation
04/12/12
BKLFinal Director's Interest Notice
31/10/12
BKLResults of Meeting
25/10/12
BKLChairman's Address to Shareholders
25/10/12
BKLFirst Quarter Letter to Shareholders
25/10/12
BKLFirst Quarter Results Announcement
25/10/12PRICE SENSITIVE
BKLChange of Director's Interest Notice
22/10/12
BKLChange of Director's Interest Notice
22/10/12
BKLChange of Director's Interest Notice
22/10/12
BKLChange of Director's Interest Notice
22/10/12
BKLChange of Director's Interest Notice
22/10/12
BKLAppendix 3B
18/10/12
BKL2012 Final Dividend DRP Share Price
11/10/12
BKLNotice of Annual General Meeting/Proxy Form
21/09/12
BKLChange of Director's Interest Notice
14/09/12
BKLAppendix 4E - Amended
30/08/12
BKLAnalysts Briefing
30/08/12
BKLFourth Quarter Letter to Shareholders
29/08/12
BKLBlackmores Full Year Results
29/08/12
BKLAnnual Report to Shareholders
29/08/12
BKLAppendix 4E
29/08/12PRICE SENSITIVE
BKLAppendix 3B
12/07/12
BKLCompletion of Acquisition of FIT-BioCeuticals Limited
05/07/12
BKLAnalyst Briefing
03/07/12
BKLAcquisition of FIT-BioCeuticals Limited
02/07/12PRICE SENSITIVE
BKLThird Quarter Letter to Shareholders
19/04/12
BKLThird Quarter Results Announcement
19/04/12PRICE SENSITIVE
BKLChange in substantial holding
28/03/12
BKLChange of Director's Interest Notice
20/03/12
BKLChange of Director's Interest Notice
20/03/12
BKLAnalyst Briefing
24/02/12
BKLHalf Yearly Report and Accounts
23/02/12PRICE SENSITIVE
BKLHalf Year Results Announcement
23/02/12
BKLHalf Year Letter to Shareholders
23/02/12
BKLAppendix 3B
11/01/12
BKLResults of Meeting
27/10/11
BKLChairman's Address to Shareholders
27/10/11
BKLFirst Quarter Results Announcement
27/10/11PRICE SENSITIVE
BKLFirst Quarter Letter to Shareholders
27/10/11
BKLNotice of Annual General Meeting/Proxy Form
23/09/11
BKLChange of Director's Interest Notice
01/09/11
BKLAppendix 3B
01/09/11
BKLAnalyst Briefing
18/08/11
BKLFourth Quarter Letter to Shareholders
18/08/11
BKLBlackmores Full Year Results
18/08/11
BKLAnnual Report to shareholders
18/08/11
BKLAppendix 4E
18/08/11PRICE SENSITIVE
BKLAppendix 3B
08/07/11
BKLCEO Presentation, Stockbrokers Association of Australia
30/05/11
BKLAnalysts Briefing
18/05/11
BKLAnalyst Briefing
21/04/11
BKLThird Quarter Letter to Shareholders
20/04/11
BKLThird Quarter Results Announcement
20/04/11PRICE SENSITIVE
BKLTrading Policy - Blackmores Shares - Revised
24/02/11
BKLAnalyst Briefing
23/02/11
BKLHalf Year Letter to Shareholders
22/02/11
refresh Created with Sketch. REFRESH
 

Top Stories

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Banshee's historic trenches prove rich in antimony and gold for GDM Great Divide Mining Ltd has found high-grade antimony and gold through geochemical sampling at its Banshee prospect in Queensland
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.